![]() |
市場調查報告書
商品編碼
2008897
腦積水引流裝置市場報告:按類型、產品類型、年齡層、最終用戶和地區分類,2026-2034 年Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2026-2034 |
||||||
2025年,全球腦積水引流裝置市場規模達4.831億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到6.518億美元,2026年至2034年的複合年成長率(CAGR)為3.28%。推動該市場成長的主要因素包括水腦症的上升、醫療基礎設施的進步以及分流器設計的技術創新。此外,先天性水腦症病例的增加和兒童人口的快速成長也顯著促進了市場成長。
先天性病例增加和兒童人口增加
全球腦積水引流裝置市場的關鍵趨勢是嬰兒童先天性水腦症的不斷上升。此外,兒童人口的快速成長也對市場動態起著至關重要的作用。根據世界人口統計網站(The World Counts)的數據顯示,每天有38.5萬名嬰兒出生,每年總計1.4億人。先天性腦積水病例的增加正在推動對兒童腦積水分流器解決方案的需求。約翰霍普金斯醫院的數據顯示,美國每1,000名新生兒中就有1至2名患有先天性水腦症。因此,製造商現在開始意識到這一年齡層兒童獨特的生理和解剖需求,並致力於設計專為兒童和嬰兒設計的腦積水分流器。
先進技術的迅速傳播
全球腦積水引流裝置市場正呈現出顯著的趨勢,即擴大採用先進技術,包括防虹吸分流器和可程式設計分流器。這些創新技術能夠精確調節腦脊髓液流量,進而改善患者預後。發表在《神經外科雜誌》上的一項研究表明,在水腦症治療中,可程式設計分流器的再次手術率低於非可程式設計分流器。因此,可程式分流器已被證明更具成本效益。研究發現,7% 的可程式分流器患者需要再次手術,而非可程式分流器的再次手術率則高達 21.6%。此外,遠端監測和遠端保健系統的引入正在改善術後護理,減少患者頻繁就醫的需求,進一步加速分流術的普及應用。
新興市場產品普及率的擴大
在全球腦積水引流裝置市場,新興市場前景光明,主要驅動力在於醫療保健支出不斷成長和醫療基礎設施不斷完善。中國和印度等國的腦積水引流裝置使用率不斷提高,這主要得益於患者意識的增強和醫療設施的改善。產業報告預測,亞太地區經濟將在2024年保持強勁成長,其中印度GDP預計將成長5%。政府為改善醫療設施所採取的舉措,以及大型企業為滿足當地未被滿足的醫療需求而加強在這些經濟體的業務佈局,都將進一步推動市場擴張。
The global hydrocephalus shunts market size reached USD 483.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 651.8 Million by 2034, exhibiting a growth rate (CAGR) of 3.28 % during 2026-2034. T he market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.
Increasing Congenital Cases and Pediatric Population
A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.
Rapid Adoption of Advanced Technologies
The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.
Increasing Product Prevalence in Emerging Economies
The global hydrocephalus shunts market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.
Ventriculo-peritoneal accounts for the majority of the market share
The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.
Hydrocephalus valves hold the largest share of the industry
Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.
Children represent the leading market segment
Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.
Hospitals exhibit a clear dominance in the market
Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.
North America leads the market, accounting for the largest hydrocephalus shunts market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.
North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.
The global hydrocephalus shunts market outlook is represented by an intense competition due to the presence of key companies that are dominating the market share through broad product portfolios, innovative technologies, and strategic acquisitions and partnerships. For instance, in July 2023, CereVasc formed a strategic partnership with LianMedical, a China-based medical device company, to release its eShunt system and other related products to providers and patients in East Asian countries China, Hong Kong, Taiwan, and Macaw. Emerging companies are establishing their positions by emphasizing on cost-efficient product formulations and advancements in technology. Regional competitors also contribute substantially, utilizing regulatory policies and local market expertise. Robust research and development, coupled with continuous striving to improve patient outcomes, further fuel the competition and contribute to market evolution.